Lidocaine

CHEMBL79 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
234.3 g/mol
LogP
2.3
Phase
4

A local anesthetic and antiarrhythmic used for numbing procedures, nerve blocks, and treating certain heart rhythm abnormalities. It works by blocking sodium channels in nerve and heart muscle cells to prevent electrical signals from propagating.

आणविक भार

234.3400 g/mol

LogP

2.30

TPSA

32.30 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

क्रिया का तंत्र

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CC(=O)Nc1c(C)cccc1C

InChI

InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)

Molecular Formula

C14H22N2O

HBD / HBA

1 / 2

घूर्णनीय बंधन

5

भारी परमाणु

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

A local anesthetic and antiarrhythmic used for numbing procedures, nerve blocks, and treating certain heart rhythm abnormalities. It works by blocking sodium channels in nerve and heart muscle cells to prevent electrical signals from propagating.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Lidocaine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL79. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3676. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.